Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Jul;40(7):1604–1609. doi: 10.1128/aac.40.7.1604

New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents.

A M Flattery 1, G K Abruzzo 1, C J Gill 1, J G Smith 1, K Bartizal 1
PMCID: PMC163381  PMID: 8807048

Abstract

A new model for the evaluation of antifungal compounds against oropharyngeal and gastrointestinal mucosal colonization by Candida albicans was developed. To simulate the immune deficiency observed in AIDS patients, mice were depleted of CD4+ T lymphocytes by the injection of either GK1.5 hybridoma cells or purified anti-CD4+ T lymphocytes by the injection of either GK1.5 hybridoma cells or purified anti-CD4+ monoclonal antibody derived from GK1.5 hybridoma cells in tissue culture. Fluorescence-activated cell sorter analysis of splenic lymphocytes confirmed the elimination of the CD4+ T-cell population. Gentamicin, a broad-spectrum, nonabsorbable aminoglycoside antibiotic, was given via the drinking water to reduce the normal gastrointestinal microflora, allowing less competition for colonization of the gastrointestinal tract by the C. albicans isolates. Mice were challenged by gavage and swabbing their oral mucosae with a pure culture of C. albicans. Gentamicin was withdrawn 3 days postchallenge, and antifungal compounds were administered via the drinking water ad libitum at concentrations ranging from 25 to 400 micrograms/ml. L-693989, a water-soluble phosphorylated cyclic lipopeptide prodrug of pneumocandin Bo, and L-733560, a semisynthetic derivative of pneumocandin Bo, are inhibitors of 1,3-beta-D-glucan synthesis that exhibit potent in vivo anti-Candida spp. and anti-Pneumocystis carinii activities. The efficacies of L-693989, L-733560, fluconazole, ketoconazole, and nystatin were evaluated in this new oropharyngeal and gastrointestinal model of mucosal colonization. L-693989, L-733560, fluconazole, and ketoconazole showed superior efficacies in reducing the numbers of C. albicans CFU per gram of feces and the numbers of oral CFU relative to those in sham-treated controls in this model, while nystatin was moderately effective in reducing oral and fecal colonization by C. albicans in this model.

Full Text

The Full Text of this article is available as a PDF (516.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arendorf T. M., Walker D. M. The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol. 1980;25(1):1–10. doi: 10.1016/0003-9969(80)90147-8. [DOI] [PubMed] [Google Scholar]
  2. Balish E., Balish M. J., Salkowski C. A., Lee K. W., Bartizal K. F. Colonization of congenitally athymic, gnotobiotic mice by Candida albicans. Appl Environ Microbiol. 1984 Apr;47(4):647–652. doi: 10.1128/aem.47.4.647-652.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Balish E., Filutowicz H., Oberley T. D. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect Immun. 1990 Jan;58(1):107–113. doi: 10.1128/iai.58.1.107-113.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bistoni F., Cenci E., Mencacci A., Schiaffella E., Mosci P., Puccetti P., Romani L. Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J Infect Dis. 1993 Dec;168(6):1449–1457. doi: 10.1093/infdis/168.6.1449. [DOI] [PubMed] [Google Scholar]
  5. Bodey G. P. Candidiasis in cancer patients. Am J Med. 1984 Oct 30;77(4D):13–19. [PubMed] [Google Scholar]
  6. Cantorna M. T., Balish E. Acquired immunity to systemic candidiasis in immunodeficient mice. J Infect Dis. 1991 Nov;164(5):936–943. doi: 10.1093/infdis/164.5.936. [DOI] [PubMed] [Google Scholar]
  7. Cantorna M. T., Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun. 1990 Apr;58(4):1093–1100. doi: 10.1128/iai.58.4.1093-1100.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cantorna M. T., Balish E. Role of CD4+ lymphocytes in resistance to mucosal candidiasis. Infect Immun. 1991 Jul;59(7):2447–2455. doi: 10.1128/iai.59.7.2447-2455.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cole G. T., Lynn K. T., Seshan K. R. An animal model for oropharyngeal, esophageal and gastric candidosis. Mycoses. 1990 Jan;33(1):7–19. doi: 10.1111/myc.1990.33.1.7. [DOI] [PubMed] [Google Scholar]
  10. Domer J. E., Hector R. F. Enhanced immune responses in mice treated with penicillin-tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans. Antimicrob Agents Chemother. 1987 May;31(5):691–697. doi: 10.1128/aac.31.5.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ekenna O., Fader R. C. Effect of thermal injury and immunosuppression on the dissemination of Candida albicans from the mouse gastrointestinal tract. J Burn Care Rehabil. 1989 Mar-Apr;10(2):138–145. doi: 10.1097/00004630-198903000-00007. [DOI] [PubMed] [Google Scholar]
  12. Epstein J. B., Truelove E. L., Izutzu K. T. Oral candidiasis: pathogenesis and host defense. Rev Infect Dis. 1984 Jan-Feb;6(1):96–106. doi: 10.1093/clinids/6.1.96. [DOI] [PubMed] [Google Scholar]
  13. Field L. H., Pope L. M., Cole G. T., Guentzel M. N., Berry L. J. Persistence and spread of Candida albicans after intragastric inoculation of infant mice. Infect Immun. 1981 Feb;31(2):783–791. doi: 10.1128/iai.31.2.783-791.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Glatt A. E., Chirgwin K., Landesman S. H. Current concepts. Treatment of infections associated with human immunodeficiency virus. N Engl J Med. 1988 Jun 2;318(22):1439–1448. doi: 10.1056/NEJM198806023182206. [DOI] [PubMed] [Google Scholar]
  15. Gottlieb M. S., Schroff R., Schanker H. M., Weisman J. D., Fan P. T., Wolf R. A., Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981 Dec 10;305(24):1425–1431. doi: 10.1056/NEJM198112103052401. [DOI] [PubMed] [Google Scholar]
  16. Guentzel M. N., Herrera C. Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy. Infect Immun. 1982 Jan;35(1):222–228. doi: 10.1128/iai.35.1.222-228.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hector R. F., Domer J. E. Mammary gland contamination as a means of establishing long-term gastrointestinal colonization of infant mice with Candida albicans. Infect Immun. 1982 Nov;38(2):788–790. doi: 10.1128/iai.38.2.788-790.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jorizzo J. L., Sams W. M., Jr, Jegasothy B. V., Olansky A. J. Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model. Ann Intern Med. 1980 Feb;92(2 Pt 1):192–195. doi: 10.7326/0003-4819-92-2-192. [DOI] [PubMed] [Google Scholar]
  19. Kennedy M. J., Volz P. A. Dissemination of yeasts after gastrointestinal inoculation in antibiotic-treated mice. Sabouraudia. 1983 Mar;21(1):27–33. doi: 10.1080/00362178385380051. [DOI] [PubMed] [Google Scholar]
  20. Klein R. S., Harris C. A., Small C. B., Moll B., Lesser M., Friedland G. H. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med. 1984 Aug 9;311(6):354–358. doi: 10.1056/NEJM198408093110602. [DOI] [PubMed] [Google Scholar]
  21. McFadden D. C., Powles M. A., Smith J. G., Flattery A. M., Bartizal K., Schmatz D. M. Use of anti-CD4+ hybridoma cells to induce Pneumocystis carinii in mice. Infect Immun. 1994 Nov;62(11):4887–4892. doi: 10.1128/iai.62.11.4887-4892.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Meunier-Carpentier F., Kiehn T. E., Armstrong D. Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am J Med. 1981 Sep;71(3):363–370. doi: 10.1016/0002-9343(81)90162-5. [DOI] [PubMed] [Google Scholar]
  23. Musial C. E., Cockerill F. R., 3rd, Roberts G. D. Fungal infections of the immunocompromised host: clinical and laboratory aspects. Clin Microbiol Rev. 1988 Oct;1(4):349–364. doi: 10.1128/cmr.1.4.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Myerowitz R. L., Pazin G. J., Allen C. M. Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology. Am J Clin Pathol. 1977 Jul;68(1):29–38. doi: 10.1093/ajcp/68.1.29. [DOI] [PubMed] [Google Scholar]
  25. Narayanan R., Joyce W. A., Greenfield R. A. Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun. 1991 Jun;59(6):2116–2119. doi: 10.1128/iai.59.6.2116-2119.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nolting S., Fegeler K., Koralewski F., Ludwig G. Einfluss von Antibiotika und Cytostatika auf die experimentelle Candidose der Maus. Mykosen. 1975 Jul;18(7):309–313. [PubMed] [Google Scholar]
  27. Pankhurst C., Peakman M. Reduced CD4 + T cells and severe oral candidiasis in absence of HIV infection. Lancet. 1989 Mar 25;1(8639):672–672. doi: 10.1016/s0140-6736(89)92176-4. [DOI] [PubMed] [Google Scholar]
  28. Pope L. M., Cole G. T., Guentzel M. N., Berry L. J. Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge. Infect Immun. 1979 Aug;25(2):702–707. doi: 10.1128/iai.25.2.702-707.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rogers T. J., Balish E. Immunity to Candida albicans. Microbiol Rev. 1980 Dec;44(4):660–682. doi: 10.1128/mr.44.4.660-682.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Samonis G., Anaissie E. J., Rosenbaum B., Bodey G. P. A model of sustained gastrointestinal colonization by Candida albicans in healthy adult mice. Infect Immun. 1990 Jun;58(6):1514–1517. doi: 10.1128/iai.58.6.1514-1517.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Smith D. K., Neal J. J., Holmberg S. D. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med. 1993 Feb 11;328(6):373–379. doi: 10.1056/NEJM199302113280601. [DOI] [PubMed] [Google Scholar]
  32. Walsh T. J., Hamilton S. R., Belitsos N. Esophageal candidiasis. Managing an increasingly prevalent infection. Postgrad Med. 1988 Aug;84(2):193-6, 201-5. doi: 10.1080/00325481.1988.11700377. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES